Inflammatory Breast Cancer

Inflammatory breast cancer gets its name not because the breast is actually inflamed in the traditional sense, but because its hallmark symptoms — redness, swelling, warmth, and skin that looks dimpled or ridged like an orange peel (a texture called peau d'orange in medical shorthand) — mimic the appearance of a breast infection or mastitis. What is actually happening is that cancer cells are blocking the lymphatic vessels just beneath the skin of the breast, causing fluid to back up and creating that distinctive appearance. Because there is often no defined lump, IBC can be missed or misidentified, which is why knowing these visual and tactile signs matters.

IBC typically progresses quickly, which is why prompt evaluation is critical if you notice these symptoms. Diagnosis involves imaging — usually a mammogram and ultrasound, sometimes MRI — along with a biopsy of both the breast tissue and the skin. IBC is almost always at least stage III at diagnosis and is frequently HER2-positive or triple-negative, subtypes that are targeted by specific therapies.

Treatment for IBC typically begins with chemotherapy (often called neoadjuvant chemotherapy, given before surgery) to shrink the cancer and reduce the burden in the lymphatic system. Surgery — usually a mastectomy — follows, and radiation therapy is typically part of the plan as well. Targeted therapies are added when the cancer's receptor profile supports their use. Despite its aggressive nature, many women with IBC respond well to treatment, and research into IBC-specific approaches continues to advance.

Because inflammatory breast cancer does not follow the familiar script of a breast lump, many women — and even some healthcare providers — do not immediately recognize it for what it is. Awareness of IBC's distinctive skin changes can be genuinely lifesaving. If your breast suddenly becomes red, warm, swollen, or visibly different in texture, and especially if antibiotics prescribed for suspected mastitis are not resolving the symptoms within a week or two, pushing for imaging and further evaluation is appropriate and important.

IBC disproportionately affects younger women and Black women, who are diagnosed with IBC at higher rates than white women. If you have risk factors or a family history of aggressive breast cancer, discussing IBC awareness with your provider is worthwhile. Speed of response matters more with IBC than with many other breast cancers — the sooner treatment begins, the better the odds of a strong response. Connecting with an oncology center experienced with IBC is also worth considering, given how specialized its management can be.